G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 065.25 INR -1.05%
Market Cap: 286.1B INR
Have any thoughts about
Global Health Ltd?
Write Note

Global Health Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Global Health Ltd
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
G
Global Health Ltd
NSE:MEDANTA
Other Receivables
â‚ą108.9m
CAGR 3-Years
98%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Other Receivables
â‚ą101.2m
CAGR 3-Years
36%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
Other Receivables
â‚ą2.4B
CAGR 3-Years
55%
CAGR 5-Years
26%
CAGR 10-Years
N/A
F
Fortis Healthcare Ltd
NSE:FORTIS
Other Receivables
â‚ą281.6m
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
-19%
Max Healthcare Institute Ltd
NSE:MAXHEALTH
Other Receivables
â‚ą215.1m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Narayana Hrudayalaya Ltd
NSE:NH
Other Receivables
â‚ą46.7m
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Global Health Ltd
Glance View

Market Cap
286B INR
Industry
Health Care

Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, air ambulance, patient support services, and others.

MEDANTA Intrinsic Value
794.33 INR
Overvaluation 25%
Intrinsic Value
Price
G

See Also

What is Global Health Ltd's Other Receivables?
Other Receivables
108.9m INR

Based on the financial report for Mar 31, 2024, Global Health Ltd's Other Receivables amounts to 108.9m INR.

What is Global Health Ltd's Other Receivables growth rate?
Other Receivables CAGR 3Y
98%

Over the last year, the Other Receivables growth was 11%. The average annual Other Receivables growth rates for Global Health Ltd have been 98% over the past three years .

Back to Top